Skip to main content
Caplight Logo









IOP Medical

IOP Medical

Private
IsraelHealthcare & Life Scienceshttps://iop-medical.com/

Last Round

Grant

Jun 1, 2023

Company Overview

IOP Medical operates in Healthcare & Life Sciences and is based in Israel. Its latest recorded funding round was a Grant round in June 2023.

IOP Medical is an ophthalmic technology company that develops implantable sensors for continuous self-monitoring of intraocular pressure to manage glaucoma.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Sensors, Healthcare Analytics

Business Model

B2B2C

Customer Profile

Hardware Sales, Data as a Service

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

IOP Medical Comparables

Compare IOP Medical with similar companies based on industry and business-model similarity.

IOP Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Injectsense, Inc.
90%
Implandata Ophthalmic Products
88%
AcuMEMS
84%
Book a demo to see all comparables

For institutional investors. Book with your work email.

IOP Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 1, 2023
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

IOP Medical Investors

Notable investors and investment history

IOP Medical investors
InvestorRounds
Israel Innovation AuthorityGrant
Galil Ofek InnovationAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 28, 2025

    Monthly visitors grew 161% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

IOP Medical Filings

Explore SEC and related filing metadata, where available.

IOP Medical filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about IOP Medical's valuation, stock price, and market status.

Is IOP Medical a public or private company?

IOP Medical is a private company.

What is the current stock price of IOP Medical?

IOP Medical is a private company, so its shares have no public market price. Caplight tracks IOP Medical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is IOP Medical worth (valuation)?

Valuation information for IOP Medical is not publicly available.

Can I buy IOP Medical stock?

IOP Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was IOP Medical's last funding round?

IOP Medical's most recent funding round was Grant on June 1, 2023.

Who are the main investors in IOP Medical?

Key investors in IOP Medical include Israel Innovation Authority, Galil Ofek Innovation.

Will IOP Medical IPO soon?

No public IPO plans have been announced for IOP Medical.

How can I track IOP Medical secondary market activity?

Caplight tracks bids, offers, and trades in IOP Medical's shares on secondary markets.

Firmographic Details

HeadquartersIsrael
Employee Range6
Year Founded2018
Last FundingJun 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?